1. Home
  2. CVS vs SNY Comparison

CVS vs SNY Comparison

Compare CVS & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVS Health Corporation

CVS

CVS Health Corporation

HOLD

Current Price

$78.15

Market Cap

100.7B

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$46.01

Market Cap

119.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVS
SNY
Founded
1963
1994
Country
United States
France
Employees
N/A
N/A
Industry
Retail-Drug Stores and Proprietary Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
100.7B
119.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CVS
SNY
Price
$78.15
$46.01
Analyst Decision
Strong Buy
Buy
Analyst Count
18
6
Target Price
$94.33
$61.50
AVG Volume (30 Days)
11.1M
4.7M
Earning Date
02-10-2026
01-29-2026
Dividend Yield
3.39%
3.48%
EPS Growth
N/A
44.16
EPS
1.39
7.52
Revenue
$399,834,000,000.00
$54,850,299,422.00
Revenue This Year
$3.67
$2.70
Revenue Next Year
$5.38
$6.84
P/E Ratio
$56.46
$12.14
Revenue Growth
7.87
5.49
52 Week Low
$58.35
$44.62
52 Week High
$85.15
$60.12

Technical Indicators

Market Signals
Indicator
CVS
SNY
Relative Strength Index (RSI) 52.91 44.94
Support Level $73.00 $47.39
Resistance Level $78.96 $49.42
Average True Range (ATR) 2.75 0.74
MACD 0.22 0.08
Stochastic Oscillator 96.67 31.32

Price Performance

Historical Comparison
CVS
SNY

About CVS CVS Health Corporation

CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: